Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “multiple sclerosis”

Covid-19 Vaccine Immune Response in Multiple SclerosisActive Not Recruiting
NCT05269888N/AUpdated Feb 4, 2025
Sponsor: University Hospitals of North Midlands NHS Trust
Multiple Sclerosis
United Kingdom
Fatigue Management Programs for People With MSCompleted
NCT03550170NAUpdated Feb 4, 2025
Sponsor: Case Western Reserve University
Multiple Sclerosis
United States
Genetics and Environment iNtersection In the ALS-FTD Spectrum: an Italian Twins Cohort studY With a Multi-Omics ApproachRecruiting
NCT06595212N/AUpdated Feb 4, 2025
Sponsor: Azienda Ospedaliero-Universitaria di Modena
ALS · FTD
Italy
Efficacy and Safety of Oral Bosentan on Healing/Prevention of Digital (Finger) Ulcers in Patients With SclerodermaCompleted
NCT00077584Phase 3Updated Feb 3, 2025
Sponsor: Actelion
Digital Ulcers · Systemic Sclerosis
A Study of Suvorexant in Patients With Multiple Sclerosis Fatigue and InsomniaCompleted
NCT03110315Phase 4Updated Feb 3, 2025
Sponsor: Theodore R. Brown, MD MPH
Multiple Sclerosis · Fatigue · Insomnia
United States
Balance Targeted Exercises for Individuals With MSCompleted
NCT06159361NAUpdated Jan 31, 2025
Sponsor: University of Miami
Multiple Sclerosis
United States
Effectiveness of a Digital Health Application for Multiple Sclerosis (Levidex)Completed
NCT06090305NAUpdated Jan 30, 2025
Sponsor: Gaia AG
Multiple Sclerosis
Germany
Effects of Virtual Reality on Sleep Quality and Mental Well-beingCompleted
NCT06074419NAUpdated Jan 24, 2025
Sponsor: Ataturk University
Nursing Caries
Turkey (Türkiye)
Natalizumab in Preventing Post-partum Relapses in Multiple SclerosisCompleted
NCT03046251Phase 4Updated Jan 24, 2025
Sponsor: State University of New York at Buffalo
Multiple Sclerosis
United States
Telehealth Pain Self-Management for Employed AdultsCompleted
NCT04248725NAUpdated Jan 24, 2025
Sponsor: University of Washington
Chronic Pain · Brain Injuries, Traumatic · Multiple Sclerosis · Spinal Cord Injuries
United States
Relıabılıty and valıdıty of the supıne-to-stand Test wıth Multiple SclerosisCompleted
NCT06790992N/AUpdated Jan 24, 2025
Sponsor: Sanko University
Multiple Sclerosis
Turkey (Türkiye)
First-in-Human Trial in Healthy Adult Volunteers to Evaluate Safety, Tolerability and PK of LAPIX Study Drug; LPX-TI641Completed
NCT05853835Phase 1Updated Jan 23, 2025
Sponsor: LAPIX Therapeutics Inc.
Autoimmune Diseases · Multiple Sclerosis
United States, Jordan
Predicting Epileptogenic Tubers in Patients with Tuberous Sclerosis ComplexCompleted
NCT06789419N/AUpdated Jan 23, 2025
Sponsor: Beijing Children's Hospital
Tuberous Sclerosis Complex
Intermediate-Size Expanded Access Protocol (EAP) for LP352Available
NCT06149663N/AUpdated Jan 22, 2025
Sponsor: Longboard Pharmaceuticals
Dravet Syndrome · Lennox Gastaut Syndrome · Developmental and Epileptic Encephalopathies
United States, Australia
Extension to the MAGNIFY MS Trial on Mavenclad® (Magnify MS Extension)Completed
NCT04783935Phase 4Updated Jan 22, 2025
Sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Multiple Sclerosis
Australia, Austria, Canada, Czechia, Finland +9 more
The Gilenya Pregnancy RegistryCompleted
NCT01285479N/AUpdated Jan 22, 2025
Sponsor: Novartis Pharmaceuticals
Multiple Sclerosis
United States, Argentina, Australia, Austria, Belgium +29 more
Safety, Tolerability, and Pharmacokinetics of FHND1002 Granules in Healthy AdultsEnrolling By Invitation
NCT06782958Phase 1Updated Jan 20, 2025
Sponsor: Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd.
Amyotrophic Lateral Sclerosis (ALS)
China
The Effectiveness and Safety of Resective Epilepsy Surgery for TREActive Not Recruiting
NCT04198181N/AUpdated Jan 17, 2025
Sponsor: Beijing Children's Hospital
Tuberous Sclerosis Complex · Epilepsy
China
Multimodal Imaging of MS Reveals the Smoldering InflammationActive Not Recruiting
NCT04126772N/AUpdated Jan 15, 2025
Sponsor: Turku University Hospital
Multiple Sclerosis
Finland
Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Participants With Early Stage Relapsing Remitting Multiple Sclerosis (RRMS)Terminated
NCT03085810Phase 3Updated Jan 15, 2025
Sponsor: Hoffmann-La Roche
Multiple Sclerosis, Relapsing-Remitting
United States, Argentina, Australia, Austria, Belgium +24 more
Multidimensional Integrated Assessment to Test the Efficacy and Response to Ozanimod in Multiple Sclerosis.Terminated
NCT05777902Phase 4Updated Jan 15, 2025
Sponsor: I.R.C.C.S. Fondazione Santa Lucia
Multiple Sclerosis
Italy
Effect of Cladribine Treatment on Microglial Activation in the CNSActive Not Recruiting
NCT04239820N/AUpdated Jan 15, 2025
Sponsor: Turku University Hospital
Multiple Sclerosis
Finland
Clinical Trial Data Set Re-use With Statistical Methodologies Tailored for Clinical Trials in Rare DiseasesCompleted
NCT05199402N/AUpdated Jan 15, 2025
Sponsor: Imagine Institute
Tuberous Sclerosis · Epilepsy
France
Kesimpta (Ofatumumab) Pregnancy RegistryRecruiting
NCT05634967N/AUpdated Jan 14, 2025
Sponsor: Novartis Pharmaceuticals
Multiple Sclerosis · Pregnancy
United States
Stem Cells in Rapidly Evolving Active Multiple SclerosisCompleted
NCT01606215Phase 1, Phase 2Updated Jan 14, 2025
Sponsor: Imperial College London
Multiple Sclerosis
United Kingdom

Previous page Next page